BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8584638)

  • 1. [Diagnosis of recurrence of cervix carcinoma using dynamic MRI: correlation of pharmacokinetic analysis and histopathology].
    Hawighorst H; Knapstein PG; Schaeffer U; Brix G; Weikel P; Essig M; Zuna I; Knopp MV
    Radiologe; 1995 Dec; 35(12):945-51. PubMed ID: 8584638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent rectal cancer: diagnosis with dynamic MR imaging.
    Müller-Schimpfle M; Brix G; Layer G; Schlag P; Engenhart R; Frohmuller S; Hess T; Zuna I; Semmler W; van Kaick G
    Radiology; 1993 Dec; 189(3):881-9. PubMed ID: 8234720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markedly high signal intensity lesions in the uterine cervix on T2-weighted imaging: differentiation between mucin-producing carcinomas and nabothian cysts.
    Li H; Sugimura K; Okizuka H; Yoshida M; Maruyama R; Takahashi K; Miyazaki K
    Radiat Med; 1999; 17(2):137-43. PubMed ID: 10399782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of uterine cervical carcinoma: diagnostic comparison of endorectal surface coil and standard body coil MRI.
    Kaji Y; Sugimura K; Kitao M; Ishida T
    J Comput Assist Tomogr; 1994; 18(5):785-92. PubMed ID: 8089330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
    Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
    Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging.
    Hricak H; Swift PS; Campos Z; Quivey JM; Gildengorin V; Göranson H
    Radiology; 1993 Nov; 189(2):381-8. PubMed ID: 8210364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
    Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
    Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
    AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
    Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
    Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer.
    Torricelli P; Pecchi A; Luppi G; Romagnoli R
    Abdom Imaging; 2003; 28(1):19-27. PubMed ID: 12483379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural network approach to the segmentation and classification of dynamic magnetic resonance images of the breast: comparison with empiric and quantitative kinetic parameters.
    Szabó BK; Aspelin P; Wiberg MK
    Acad Radiol; 2004 Dec; 11(12):1344-54. PubMed ID: 15596372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy.
    Yamashita Y; Baba T; Baba Y; Nishimura R; Ikeda S; Takahashi M; Ohtake H; Okamura H
    Radiology; 2000 Sep; 216(3):803-9. PubMed ID: 10966715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of the cervix: dynamic MR imaging.
    Yamashita Y; Takahashi M; Sawada T; Miyazaki K; Okamura H
    Radiology; 1992 Mar; 182(3):643-8. PubMed ID: 1535875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
    Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
    Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.